Search results for "hypoallergen"

showing 6 items of 6 documents

Dialyzability of iron, zinc, and copper of different types of infant formulas marketed in Spain

1998

The bioavailability of trace elements in infant formulas is affected by different physiological and dietetic factors. In vitro methods based on element dialyzability have been proposed to estimate the bioavailability. Infant formulas of the same type but from different manufacturers can differ in the salt used for supplementation and in the contents of other components that can affect mineral bioavailability. The aim of our study is to estimate the dialyzability of iron, zinc, and copper of formulas marketed in Spain, in order to detect possible differences in formulas of the same type coming from different manufacturers. At the same time, the effects of the type of formula, the composition…

ChemistryIronSpectrophotometry AtomicEndocrinology Diabetes and MetabolismBiochemistry (medical)Clinical Biochemistrychemistry.chemical_elementHypoallergenicGeneral MedicineZincBiochemistryCopperBioavailabilityInorganic ChemistryZincMineral bioavailabilitySpainCaseinInfant FoodSpectrophotometry UltravioletComposition (visual arts)Protein hydrolysatesFood scienceDialysisCopper
researchProduct

Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy

2006

Background Despite the use of conventional allergen-specific immunotherapy in clinical practice, more defined, efficient, and safer allergy vaccines are required. Objective The aim of the study was to obtain hypoallergenic molecules by deleting B-cell epitopes, which could potentially be applied to Parietaria judaica pollen allergy treatment. Methods Three hybrid molecules (Q1, Q2, and Q3) derived from fragments of the 2 major P judaica pollen allergens, Par j 1 and Par j 2, were engineered by means of PCR. Hybrid structures were compared with their natural components by means of circular dichroism, and their biologic activities were compared by using T-cell proliferation assays. Their IgE-…

AdultMaleAllergyParietariaAdolescentmedicine.medical_treatmentBlotting WesternMolecular Sequence DataImmunologyProtein EngineeringImmunoglobulin EPolymerase Chain ReactionEpitopelaw.inventionlawmedicineHumansImmunology and AllergyPlant ProteinsSkin TestsBase SequencebiologyRhinitis Allergic SeasonalHypoallergenicImmunotherapyAllergensAntigens PlantImmunoglobulin EMiddle Agedmedicine.diseasebiology.organism_classificationRecombinant ProteinsParietariaDesensitization ImmunologicImmunologyRecombinant DNAbiology.proteinParietaria judaicaPollenFemaleJournal of Allergy and Clinical Immunology
researchProduct

Fine characterization of immunological mechanisms mediated by the major allergens of Parietaria judaica and by a hypoallergenic hybrid, rPjEDcys.

2015

Allergy is a hypersensitivity disease IgE-mediated, affecting more than 25% of the population. Actually the only curative treatment of allergies is Allergen-Specific Immunotherapy (SIT). Recombinant hypoallergenic allergen derivatives with reduced allergenic activity have been engineered to reduce side effects during SIT. Parietaria judaica (Pj) pollen contains two major allergens, Par j 1 and expressing disulphide bond variants of Par j 1 and Par j 2, was generated. The aim of this research project is to compare the immunological mechanisms activated by the major allergens of Pj and by rPjEDcys. In vitro analysis suggested that rPjEDcys has a reduced allergenity and maintains T cells react…

Parietaria judaica ; recombinant allergen ; hypoallergen ; Allergen-Specific ImmunotherapyAllergen-Specific ImmunotherapySettore BIO/11 - Biologia MolecolarehypoallergenParietaria judaicarecombinant allergen
researchProduct

Fine characterization of immunological mechanisms mediated by the major allergens of Parietaria judaica and hypoallergenic hybrid, rPjEDcys.

Allergy is a hypersensitivity disease IgE-mediated, affecting more than 30% of the population living in the industrialized countries. The symptoms of allergic reactions can be transiently ameliorated pharmacologically, but the only curative treatment of allergies is Allergen-Specific Immunotherapy (SIT). Recombinant hypoallergenic derivatives with reduced allergenic activity have been engineered to reduce side effects during SIT. Parietaria judaica (Pj) pollen contains two major allergens belonging to the family of non specific-Lipid Transfer Proteins (ns-LTP): Par j 1 and Par j 2. The allergens Par j 1 and Par j 2 are recognized in approximately 95% of allergic patients. By means of DNA re…

Allergen Specific ImmunotherapySITAllergyRecombinant allergenAllergy; Parietaria judaica; Hypoallergen; Recombinant allergen; Allergen Specific Immunotherapy; SITHypoallergenSettore BIO/11 - Biologia MolecolareParietaria judaica
researchProduct

IgG, IgA, and IgE Antibodies to Cow Milk Proteins in an Allergy Prevention Study

1991

In the last few years, several trials have been carried out to determine if certain feeding regimens in neonates prevent atopic diseases1–13. In our country, there is a continuing debate about nutritional supplementation of breast milk with hydrolysate formulas: in the first days of life should only newborns at allergy risk8,9,11,14, or should all newborns be fed only breast milk? This age is claimed to be an especially vulnerable period for a sensitization against foreign proteins because of intestinal immaturity and inexperienced gut-associated lymphoid tissue15. A prospective Danish study revealed cases of cow’s milk allergy only among those breastfed infants who had received cow’s milk …

Allergybiologybusiness.industryfood and beveragesHypoallergenicMilk allergyBreast milkmedicine.diseaseImmunoglobulin Emedicine.anatomical_structureFood allergyImmunologymedicinebiology.proteinbusinessBreast feedingSensitization
researchProduct

Quality and potency profile of eight recombinant isoallergens, largely mimicking total Bet v 1-specific IgE binding of birch pollen.

2019

Background To date, only limited information on structure, expression levels and IgE binding of Bet v 1 variants, which are simultaneously expressed in birch pollen, is available. Objective To analyse and compare structure and serum IgE/IgG binding of rBet v 1 variants to Bet v 1.0101. Methods Recombinant Bet v 1 variants were studied with sera of 20 subjects allergic to birch pollen. Folding, aggregation and solubility of the rBet v 1 variants were analysed to attribute diverging IgE binding to either allergen structure or methodological features. IgE/IgG binding was studied with rBet v 1 in solution or adsorbed to solid phases. Allergen-mediated cross-linking of FceRI receptors was determ…

MaleImmunologyEnzyme-Linked Immunosorbent AssayBasophilImmunoglobulin Emedicine.disease_causeMass Spectrometrylaw.inventionAllergenlawmedicineImmunology and AllergyPotencyAnimalsHumansReceptorBetulaPlant ProteinsbiologyChemistrySpectrum AnalysisRhinitis Allergic SeasonalHypoallergenicAntigens PlantImmunoglobulin EMolecular biologyRecombinant ProteinsRatsmedicine.anatomical_structureIgG bindingImmunoglobulin Gbiology.proteinRecombinant DNAPollenFemaleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
researchProduct